Next week will see more than 150 companies from diverse sectors, including banking, pharmaceuticals, fintech, cement, and IT, ...

Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...

The midweek highlight will be Infosys Ltd’s Q1 earnings, closely watched for guidance on the IT sector. Dr Reddy’s Laboratories will also post results. Tata Consumer Products, Persistent Systems, ...

Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...

Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...

Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...

Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.

Colgate-Palmolive's forward PE ratio is 22.48 compared to Procter & Gamble's 18.84 and Unilever's 19.30, indicating that Colgate-Palmolive is over-priced relative to its peers.

Colgate-Palmolive’s chief executive recently signaled he would be open to selling the company — which has grappled with sluggish demand for its toothpaste, deodorants and food products — for ...

Colgate-Palmolive’s (NYSE: CL) stock has gone from $67.42 in November 2016 to $66.52 in November 2019. Over this period there has been a ~3% rise in total revenue and an equal drop in number of ...